2019RU071/Research Unit of Radiation Oncology, Chinese Academy of Medical Sciences[Grants and Funding] - Search Results

Year	Number of Results
2022	2
2023	3
2024	2

1

Early detection of radiation-induced myocardial damage by [(18)F]AlF-NOTA-FAPI-04 PET/CT imaging.

Wei Y, Sun Y, Liu J, Zhang G, Qin X, Xu S, Wang S, Tao Y, Pei J, Yu J. Wei Y, et al. Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):453-464. doi: 10.1007/s00259-022-05962-y. Epub 2022 Sep 19. Eur J Nucl Med Mol Imaging. 2023. PMID: 36121463

This study investigated and verified the feasibility of [(18)F]AlF-NOTA-FAPI-04 PET/CT for detecting radiation-induced myocardial damage (RIMD). METHODS: Myocardial FAPI uptake was analyzed before and during radiotherapy in thirteen ESCC patients treated with CCRT. ...The …

This study investigated and verified the feasibility of [(18)F]AlF-NOTA-FAPI-04 PET/CT for detecting radiation-induced myocardial dam …

2

Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer.

Liu Z, Yu B, Su M, Yuan C, Liu C, Wang X, Song X, Li C, Wang F, Ma J, Wu M, Chen D, Yu J, Yu Z. Liu Z, et al. BMC Med. 2023 Dec 12;21(1):493. doi: 10.1186/s12916-023-03163-4. BMC Med. 2023. PMID: 38087296 Free PMC article.

3

Inhibition of CDC20 potentiates anti-tumor immunity through facilitating GSDME-mediated pyroptosis in prostate cancer.

Wu F, Wang M, Zhong T, Xiao C, Chen X, Huang Y, Wu M, Yu J, Chen D. Wu F, et al. Exp Hematol Oncol. 2023 Aug 1;12(1):67. doi: 10.1186/s40164-023-00428-9. Exp Hematol Oncol. 2023. PMID: 37528490 Free PMC article.

4

Prophylactic cranial irradiation (PCI) versus active surveillance in patients with limited-stage small cell lung cancer: a retrospective, multicentre study.

Chen Y, Wang Y, Ren F, Huang Z, Tan B, Zhao Z, Yu X, Dong P, Yu J, Meng X. Chen Y, et al. Respir Res. 2022 Oct 2;23(1):274. doi: 10.1186/s12931-022-02196-2. Respir Res. 2022. PMID: 36184624 Free PMC article.

5

Radiation pneumonitis after concurrent aumolertinib and thoracic radiotherapy in EGFR-mutant non-small cell lung cancer patients.

Yin H, Jia W, Yu J, Zhu H. Yin H, et al. BMC Cancer. 2024 Feb 12;24(1):197. doi: 10.1186/s12885-024-11946-y. BMC Cancer. 2024. PMID: 38347438 Free PMC article.

BACKGROUND: The superior efficacy of concurrent thoracic radiotherapy (TRT) and epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) has been proven in locally advanced and advanced non-small cell lung cancer (NSCLC) patients with EGFR mutations. However, the h …

BACKGROUND: The superior efficacy of concurrent thoracic radiotherapy (TRT) and epidermal growth factor receptor tyrosine kinase inhibitors …

6

Recurrence/prognosis estimation using a molecularly positive surgical margin-based model calls for alternative curative strategies in pIIIA/N2 NSCLC.

Li L, He K, Zhou T, Xu Y, Pang J, Yu Q, Gao Y, Shi H, Zhu H, Li M, Yu J, Yuan S. Li L, et al. Mol Oncol. 2024 Feb 7. doi: 10.1002/1878-0261.13600. Online ahead of print. Mol Oncol. 2024. PMID: 38327028 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

6 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year